Stock Price, News, Quote and Profile of 180 LIFE SCIENCES CORP(NASDAQ:ATNF) stock

180 LIFE SCIENCES CORP

NASDAQ:ATNF (12/24/2024, 7:56:33 PM)

After market: 2.65 -0.25 (-8.62%)

2.9

+1.03 (+55.08%)

Chartmill TA Rating

Chartmill Setup Rating

Sector

GICS SectorHealth Care

GICS IndustryBiotechnology

GICS SubIndustryBiotechnology

Chartmill FA Rating

Valuation

Growth

Profitability

Health

Dividend

Chartmill High Growth Momentum

EPS Q2Q%96.52%

Sales Q2Q%N/A

CRS85.01

6 Month75.76%

Overview

Earnings (Last)11-07 2024-11-07/amc

Earnings (Next)N/A N/A

Ins Owners1.05%

Inst Owners0.69%

Market Cap5.74M

Shares1.98M

PEN/A

Fwd PEN/A

Dividend YieldN/A

Analysts82.86

Short Float %3.43%

Short Ratio0.03

IPO06-07 2017-06-07

Stock Screener Links

GICS Sector Stock Screener

Find competitors from the same sector on the USA

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

Company Profile

180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company is headquartered in Palo Alto, California and currently employs 4 full-time employees. The company went IPO on 2017-06-07. The firm is focused on iGaming sector, through its iGaming Technology Platform. The firm also continues to evaluate monetization strategies for its biotechnology assets.